Eva Méndez, PhD
Head Of Strategy
Biomarkers & Drugs
Eva has more than 17 years of experience in academic and industrial biomedical research. As head of several drug discovery departments at Ferrer Group, she was responsible for biotech, compound management and in vitro screening activities.
She was a member of the team responsible for the identification and evaluation of new projects, and the scientific coordinator of multidisciplinary teams involving other companies and public institutions. During her time at Ferrer she was instrumental in the identification and early selection of new molecules, some of which are currently in Phase II clinical trials.
Currently working as an independent consultant, Eva collaborates with a number of research institutions, biotech companies, private foundations, investors and other stakeholders on different aspects related to biomedicine and drug discovery and strategy.
Eva is a member of the Business Advisory Board of the Institute of Research in Biomedicine of Barcelona (IRB Barcelona) and an advisor for European Collaborative Research Projects and several companies and initiatives involved in management, consulting and investment in biomedicine and drug discovery. She is also a founding member of the Spanish Drug Discovery Network (SDDN) and a member of the teaching staff at three official biomedical Masters programs.
Eva holds a degree in BSc from the University of La Laguna and holds a PhD in Physiology from the University of Barcelona. She was an EMBO postdoctoral fellow at the University of Oslo.